Literature DB >> 3935626

Usefulness of monoclonal antibodies for detection of enzootic bovine leukemia cells.

M Onuma, Y Aida, K Okada, K Ohshima, Y Kawakami, H Izawa.   

Abstract

Monoclonal antibodies against tumor-associated antigens (TAAs) expressed in the leukemic cells of enzootic bovine leukosis (EBL) were examined for their possible usefulness in detecting EBL tumor cells. The antibodies immunohistochemically reacted with EBL tumor cells and had cytotoxic activity against the cells but not against normal adult bovine peripheral blood lymphocytes (PBL) even after activation with mitogens. The TAA-positive EBL tumor cells also had B cell surface markers. The TAA was also found in several samples of PBL taken from BLV-infected healthy cattle (8 positive out of 81 tested), as well as in PBL from 13 out of 14 cattle with lymphocytosis but no evidence of tumor. Thus, monoclonal antibodies directed against TAAs might be a useful tool not only for diagnosing EBL but also for screening of BLV-infected cattle with the potential to develop tumors in the future.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935626

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  3 in total

1.  Atypical sporadic lymphosarcoma in a 7-month-old Holstein heifer.

Authors:  P Dubreuil; A Lanevschi; M A Perrone; M Desnoyers
Journal:  Can Vet J       Date:  1998-07       Impact factor: 1.008

2.  The screening of cattle with potential for developing leukemia by using monoclonal antibody against bovine leukemia cells.

Authors:  M Onuma; Y Yasutomi; H M Okada; K Matsukawa; H Yoshikawa; T Yoshikawa; K Okada; K Takahashi; R Kirisawa; Y Kawakami
Journal:  Jpn J Cancer Res       Date:  1988-02

3.  Antitumor effect of diphtheria toxin A-chain gene-containing cationic liposomes conjugated with monoclonal antibody directed to tumor-associated antigen of bovine leukemia cells.

Authors:  S Watarai; M Onuma; Y Aida; H Kakidani; H Kodama; T Yasuda
Journal:  Jpn J Cancer Res       Date:  1998-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.